OISIN BIOTECHNOLOGIES has a total of 21 patent applications. Its first patent ever was published in 2014. It filed its patents most often in Australia, Republic of Korea and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are APTAHEM AB, RACTIGEN THERAPEUTICS and DITESAN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Republic of Korea | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Mexico | 2 | |
#7 | United States | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Brazil | 1 | |
#10 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Scholz Matthew R | 15 |
#2 | Scholz Matthew Rein | 3 |
#3 | Matthew R Scholz | 2 |
#4 | Scholz Matthew | 1 |
Publication | Filing date | Title |
---|---|---|
CA3047140A1 | Constructs for expression of therapeutic proteins in target cells | |
MX2015013590A | Systems and methods for the targeted production of a therapeutic protein within a target cell. |